Reply to: Comments on "Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial".

Koole, Simone N; Schouten, Philip C; van Driel, Willemien J; Sonke, Gabe S; Linn, Sabine C

Koole, Simone N; Schouten, Philip C; van Driel, Willemien J; Sonke, Gabe S; Linn, Sabine C.

Afiliação

Koole SN; Department of Gynecology, The Netherlands Cancer Institute, Center of Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands.
Schouten PC; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
van Driel WJ; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Sonke GS; Department of Gynecology, The Netherlands Cancer Institute, Center of Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands.
Linn SC; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Int J Cancer ; 151(11): 2057-2058, 2022 Dec 01.

Article em En | MEDLINE | ID: mdl-35857410

Assuntos

Hipertermia Induzida; Neoplasias Ovarianas; Carcinoma Epitelial do Ovário/tratamento farmacológico; Procedimentos Cirúrgicos de Citorredução/métodos; Feminino; Genômica; Humanos; Hipertermia Induzida/métodos; Quimioterapia Intraperitoneal Hipertérmica; Neoplasias Ovarianas/tratamento farmacológico; Neoplasias Ovarianas/terapia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Hipertermia Induzida Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google